Last reviewed · How we verify
Pneumococcal conjugate vaccine GSK2830929A — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Pneumococcal conjugate vaccine GSK2830929A (Pneumococcal conjugate vaccine GSK2830929A) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pneumococcal conjugate vaccine GSK2830929A TARGET | Pneumococcal conjugate vaccine GSK2830929A | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pneumococcal conjugate vaccine GSK2830929A CI watch — RSS
- Pneumococcal conjugate vaccine GSK2830929A CI watch — Atom
- Pneumococcal conjugate vaccine GSK2830929A CI watch — JSON
- Pneumococcal conjugate vaccine GSK2830929A alone — RSS
Cite this brief
Drug Landscape (2026). Pneumococcal conjugate vaccine GSK2830929A — Competitive Intelligence Brief. https://druglandscape.com/ci/pneumococcal-conjugate-vaccine-gsk2830929a. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab